Control Bionics (ASX:CBL) Beginning Cash Position : A$0.98 Mil (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Control Bionics Beginning Cash Position?

Control Bionics's Beginning Cash Position for the quarter that ended in Dec. 2024 was A$0.98 Mil.

Control Bionics's quarterly Beginning Cash Position increased from Dec. 2023 (A$0.94 Mil) to Jun. 2024 (A$1.31 Mil) but then declined from Jun. 2024 (A$1.31 Mil) to Dec. 2024 (A$0.98 Mil).

Control Bionics's annual Beginning Cash Position declined from Jun. 2022 (A$12.33 Mil) to Jun. 2023 (A$5.22 Mil) and declined from Jun. 2023 (A$5.22 Mil) to Jun. 2024 (A$0.94 Mil).

Control Bionics Beginning Cash Position Historical Data

The historical data trend for Control Bionics's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Control Bionics Beginning Cash Position Chart

Control Bionics Annual Data

Trend

Jun21

Jun22

Jun23

Jun24

Beginning Cash Position

1.43

12.33

5.22

0.94

Control Bionics Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Beginning Cash Position	Get a 7-Day Free Trial				5.21	3.11	0.94	1.31	0.98

Control Bionics Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Control Bionics Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Control Bionics's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Control Bionics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Control Bionics Ltd (ASX:CBL) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

11-13 Pearson Street, Level 4, Cremorne, VIC, AUS, 3121

Website

https://www.controlbionics.com

Control Bionics Ltd is engaged in the healthcare device business. It is involved in developing, commercializing, and selling assistive communications technology systems within the disability sector. Its core systems include NeuroNode Trilogy and NeuroNode3. These systems allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment, and external control of other devices. Geographically it derives a majority of revenue from North America and has its presence in Australia as well.